SCHEMBL1817502

SCHEMBL1817502

O=C(Nc1cccc(Cc2ncco2)c1)C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.52
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ HDAC3 O15379 3/20 0.44
▸ HDAC4 P56524 3/20 0.44
▸ HDAC1 Q13547 3/20 0.44
▸ HDAC7 Q8WUI4 3/20 0.44
▸ HDAC2 Q92769 3/20 0.44
▸ HDAC10 Q969S8 3/20 0.44
▸ HDAC11 Q96DB2 3/20 0.44
▸ HDAC8 Q9BY41 3/20 0.44
▸ HDAC6 Q9UBN7 3/20 0.44
▸ HDAC9 Q9UKV0 3/20 0.44
▸ HDAC5 Q9UQL6 3/20 0.44
▸ PDK1 Q15118 2/20 0.44
▸ PDK2 Q15119 2/20 0.44
▸ PDK3 Q15120 2/20 0.44
▸ PDK4 Q16654 2/20 0.44
▸ JAK2 O60674 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1816931 0.81 PARP1 (0.50) PARP1L3MBTL1NPC1RAB9AHDAC3
SCHEMBL1820694 0.80 PARP1 (0.52) PARP1L3MBTL1NPC1RAB9AHDAC3
SCHEMBL1825490 0.78 PARP1 (0.50) PARP1L3MBTL1NPC1RAB9AHDAC3
SCHEMBL1820074 0.78 HDAC3 (0.51) PARP1L3MBTL1NPC1RAB9AHDAC3
SCHEMBL1823308 0.76 KMT2A (0.50) PARP1L3MBTL1NPC1RAB9AHDAC3
SCHEMBL28182250 0.75 PDK1 (0.71) PARP1L3MBTL1NPC1RAB9AHDAC3
SCHEMBL14041043 0.75 L3MBTL1 (0.61) PARP1L3MBTL1NPC1RAB9AHDAC3
SCHEMBL1846042 0.75 KDM4E (0.39) L3MBTL1NPC1RAB9ATP53MEN1
SCHEMBL7101603 0.74 PARP1 (0.54) PARP1L3MBTL1NPC1RAB9AHDAC3
SCHEMBL7276139 0.74 L3MBTL1 (0.59) PARP1L3MBTL1NPC1RAB9AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461134-B2 Boron-containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2013-06-11 — — US disclosed
US-20110172187-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-07-14 — — US disclosed
WO-2011060196-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172187-A1 BORON-CONTAINING SMALL MOLECULES BCL6B, BCL6, BTD PARP1 1354/4885L3MBTL1 270/4885NPC1 1272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback